Intervention Protocol

Human parathyroid hormone for the treatment of osteoporosis in post-menopausal women

  1. Vesna Kusec1,*,
  2. Jonathan Adachi2,
  3. Peter Tugwell3,
  4. George A Wells4,
  5. Ana Marusic5,
  6. Ana Jeroncic5

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 11 NOV 2013

DOI: 10.1002/14651858.CD003111.pub2


How to Cite

Kusec V, Adachi J, Tugwell P, Wells GA, Marusic A, Jeroncic A. Human parathyroid hormone for the treatment of osteoporosis in post-menopausal women (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD003111. DOI: 10.1002/14651858.CD003111.pub2.

Author Information

  1. 1

    Clinical Hospital Centre Zagreb, Clinical Institute of Laboratory Diagnosis, Zagreb, Croatia

  2. 2

    St Joseph's Hospital, Hamilton, Ontario, Canada

  3. 3

    Faculty of Medicine, University of Ottawa, Department of Medicine, Ottawa, Ontario, Canada

  4. 4

    University of Ottawa, Department of Epidemiology and Community Medicine, Ottawa, Ontario, Canada

  5. 5

    University of Split School of Medicine, Department of Research in Biomedicine and Health, Split, Croatia

*Vesna Kusec, Clinical Institute of Laboratory Diagnosis, Clinical Hospital Centre Zagreb, Kispaticeva 12, Zagreb, 10000, Croatia. vkusec@kbc-zagreb.hr.

Publication History

  1. Publication Status: Amended to reflect a change in scope (see 'What's new')
  2. Published Online: 11 NOV 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the benefit and harm of hPTH in the treatment of postmenopausal osteoporosis.